Recorded in 2025, the Asia Pacific industry totaled USD 102.52 billion, reflecting a year-on-year growth of 12.3%.
Projections point to the Asia Pacific Infusion Services Market reaching USD 334.37 billion as of 2033, registering a CAGR of 15.9% during the forecast period.
Demographic scale and rising oncology prevalence are rapidly expanding systemic therapy administration, positioning the region as the fastest-growing infusion demand base globally.
World Health Organization regional cancer data confirm increasing incidence across East and Southeast Asia, reinforcing long-term infusion service expansion.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]